BETA: Please send your feedback!
Histogenics
HSGX:NAS
Biotechnology
—
MICRO cap
(—)
—
since start of 2021
—
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- 5
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
About
Biotechnology
Founded 2000
Histogenics Corp. engages in the development, marketing, and commercialization of musculoskeletal medicine. Its regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors to provide solutions that can be utilized individually or in concert to treat musculoskeletal-related conditions. The company was founded on June 28, 2000 and is headquartered in Waltham, MA.
website
Headquarters
Executives
Name | Title | Gender |
Jonathan I. Lieber, MBA | Chief Financial Officer | Male |
Garheng Kong, MD, PhD | Chairman | Male |
Adam D. Gridley, MBA | President, CEO & Director | Male |
Peter Hamilton, MBA | Vice President-Operations & Engineering | Male |
Stephen R. Kennedy, MBA | Chief Technology Officer | Male |
Gloria Matthews, PhD, DVM | Chief Medical Officer | Female |
Mindful Investing Summary
Histogenics - Competitors and Related Companies
How Histogenics stacks up to its peers in the Biotechnology industry or with competing business segments.
Histogenics
HSGX:NAS
Biotechnology
—
MICRO cap
(—)
—
since start of 2021
—
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- 2
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
Loading…